Annual EBITDA
$1.87B$137.00M+7.91%
Summary
- Current Value
- As of today, DGX annual EBITDA is $1.87B, up +7.91% on
- Historical Performance
- DGX annual EBITDA is down -40.84% over the past 3 years, and up +17.92% over the past 5 years
- All-Time High Comparison
- DGX annual EBITDA is currently -40.84% below its historical high of $3.16B set on
- 3-Year Low Comparison
- DGX annual EBITDA is +7.91% above its 3-year low of $1.73B reached on
- Sector Comparison
- DGX annual EBITDA is higher than 95.84% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.87B | +7.9% | -40.8% | +17.9% | +14.6% | |
| Quarterly EBITDA | $562.00M | +18.3% | +11.3% | -37.1% | +40.2% | |
| TTM EBITDA | $2.15B | +18.1% | -6.9% | +11.9% | +33.4% | |
| Price | $174.44 | +13.3% | +14.1% | +41.9% | +228.3% | |
| PE Ratio | 20.47 | +2.3% | +6.0% | +73.5% | +56.0% | |
| Annual Revenue | $9.87B | +6.7% | -8.5% | +27.8% | +32.4% | |
| Annual EPS | $7.66 | +1.9% | -50.7% | +21.9% | +98.0% | |
| Annual EBIT | $1.38B | +6.4% | -50.0% | +9.6% | +0.1% | |
| Annual Net Income | $916.00M | +1.3% | -55.8% | +3.7% | +19.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.87B | at high | |
| 5Y | $3.16B | -40.8% | |
| All | $3.16B | -40.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.73B | +7.9% | |
| 5Y | $1.73B | +7.9% | |
| All | -$502.19M | +472.2% |
EBITDA History
FAQ
What is the current annual EBITDA of DGX?
As of today, DGX annual EBITDA is $1.87B
What is 1-year change in DGX annual EBITDA?
DGX annual EBITDA is up +7.91% year-over-year
What is 3-year change in DGX annual EBITDA?
DGX annual EBITDA is down -40.84% over the past 3 years
How far is DGX annual EBITDA from its all-time high?
DGX annual EBITDA is currently -40.84% below its historical high of $3.16B set on December 31, 2021
How does DGX annual EBITDA rank versus sector peers?
DGX annual EBITDA is higher than 95.84% of companies in Healthcare sector
When is DGX next annual earnings release?
The next annual earnings release for DGX is on
Quarterly EBITDA
$562.00M$6.00M-1.06%
Summary
- Current Value
- As of today, DGX quarterly EBITDA is $562.00M, down -1.06% on
- Historical Performance
- DGX quarterly EBITDA is up +18.32% year-over-year, and up +11.29% over the past 3 years
- All-Time High Comparison
- DGX quarterly EBITDA is currently -39.57% below its historical high of $930.00M set on
- 3-Year Low Comparison
- DGX quarterly EBITDA is +38.08% above its 3-year low of $407.00M reached on an earlier date
- Sector Comparison
- DGX quarterly EBITDA is higher than 95.57% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $562.00M | -1.1% | +18.3% | +11.3% | -37.1% | |
| Annual EBITDA | $1.87B | – | +7.9% | -40.8% | +17.9% | |
| TTM EBITDA | $2.15B | +4.2% | +18.1% | -6.9% | +11.9% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| PE Ratio | 20.47 | -3.9% | +2.3% | +6.0% | +73.5% | |
| Quarterly Revenue | $2.82B | +2.0% | +13.2% | +13.3% | +1.1% | |
| Quarterly EPS | $2.15 | -13.5% | +8.0% | -0.1% | -48.0% | |
| Quarterly EBIT | $420.00M | -1.2% | +20.0% | +5.8% | -47.8% | |
| Quarterly Net Income | $257.00M | -12.9% | +8.9% | -6.2% | -56.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $568.00M | -1.1% | |
| 3Y | $568.00M | -1.1% | |
| 5Y | $930.00M | N/A | -39.6% |
| All | $930.00M | -39.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $507.00M | +10.8% | |
| 3Y | $407.00M | N/A | +38.1% |
| 5Y | $407.00M | +38.1% | |
| All | $27.70M | +1928.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DGX?
As of today, DGX quarterly EBITDA is $562.00M
What is DGX quarterly EBITDA most recent change?
DGX quarterly EBITDA was down -1.06% on September 30, 2025
What is 1-year change in DGX quarterly EBITDA?
DGX quarterly EBITDA is up +18.32% year-over-year
How far is DGX quarterly EBITDA from its all-time high?
DGX quarterly EBITDA is currently -39.57% below its historical high of $930.00M set on December 31, 2020
How does DGX quarterly EBITDA rank versus sector peers?
DGX quarterly EBITDA is higher than 95.57% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
TTM EBITDA
$2.15B$87.00M+4.23%
Summary
- Current Value
- As of today, DGX TTM EBITDA is $2.15B, up +4.23% on
- Historical Performance
- DGX TTM EBITDA is up +18.11% year-over-year, and down -6.86% over the past 3 years
- All-Time High Comparison
- DGX TTM EBITDA is currently -34.11% below its historical high of $3.26B set on
- 3-Year Low Comparison
- DGX TTM EBITDA is +19.75% above its 3-year low of $1.79B reached on
- Sector Comparison
- DGX TTM EBITDA is higher than 95.75% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.15B | +4.2% | +18.1% | -6.9% | +11.9% | |
| Annual EBITDA | $1.87B | – | +7.9% | -40.8% | +17.9% | |
| Quarterly EBITDA | $562.00M | -1.1% | +18.3% | +11.3% | -37.1% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| PE Ratio | 20.47 | -3.9% | +2.3% | +6.0% | +73.5% | |
| TTM Revenue | $10.85B | +3.1% | +13.7% | +5.4% | +29.8% | |
| TTM EPS | $8.52 | +1.9% | +14.4% | -16.0% | +5.6% | |
| TTM EBIT | $1.59B | +4.6% | +17.5% | -15.5% | +0.8% | |
| TTM Net Income | $1.02B | +2.1% | +15.0% | -22.0% | -11.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.15B | at high | |
| 3Y | $2.15B | at high | |
| 5Y | $3.26B | -34.1% | |
| All | $3.26B | -34.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.91B | N/A | +12.6% |
| 3Y | $1.79B | +19.8% | |
| 5Y | $1.79B | +19.8% | |
| All | $38.40M | +5488.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DGX?
As of today, DGX TTM EBITDA is $2.15B
What is DGX TTM EBITDA most recent change?
DGX TTM EBITDA was up +4.23% on September 30, 2025
What is 1-year change in DGX TTM EBITDA?
DGX TTM EBITDA is up +18.11% year-over-year
How far is DGX TTM EBITDA from its all-time high?
DGX TTM EBITDA is currently -34.11% below its historical high of $3.26B set on June 30, 2021
How does DGX TTM EBITDA rank versus sector peers?
DGX TTM EBITDA is higher than 95.75% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1022079/000102207925000218/0001022079-25-000218-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207925000044/0001022079-25-000044-index.htm
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx